Gland Pharma Limited (GLAND) — Announcement
Gland Pharma announced its schedule of upcoming analyst and institutional investor meetings, listing one-on-one sessions with Haitong Securities, ICICI Securities, Midas Research, and Sohum Asset on June 9-11, 2026. The notice emphasizes these meetings are subject to change due to operational exigencies and serves as a formal disclosure to stock exchanges under SEBI regulations.
About Gland Pharma Limited (GLAND)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GLAND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLAND — Free💡 Ask AI about this filing
📊 More GLAND filings
- Financial Results — 26 June 2026 Gland Pharma announced that its trading window will close on June 27, 2026, ahead of the unaudited q...
- Announcement — 22 June 2026 Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings, includ...
- 🟡 Voting Results — 18 June 2026 Gland Pharma Limited's shareholders approved the reappointment of Udo Jahannes Vetter as Independent...
- Announcement — 17 June 2026 Gland Pharma announced a schedule of analyst and institutional investor meetings, including a one-on...
- 🟡 Board Meeting — 16 June 2026 Gland Pharma disclosed that independent director Satyanarayana Murthy Chavali resigned effective Jun...
🔥 Also filed on 4 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GLAND files new disclosures
Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLAND — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research